SciELO Data

Metrics

12,778 Downloads

Featured Dataverses

In order to use this feature you must have at least one published or linked dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

Publication Year: 2024

1,051 to 1,060 of 1,579 Results

Figure_S1.jpg Jun 18, 2024 - Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects JPEG Image - 131.7 KB - MD5: 1c79e3411f777444fe34fd5c7e068152 Consort flowchart for patient enrolment, allocation, follow-up, and analysis.
Figure_S2.jpg Jun 18, 2024 - Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects JPEG Image - 514.0 KB - MD5: 59f2b6552004989213a0f76ce25a30e3 Merisis Supercell glue kits (PRFM+ stem cell) and Fabrication steps of Supercell glue. A - Withdrawal of 9 ml of venous blood; B - Merisis stem cell tube; C blood transferred to stem cell tube; D – Centrifugation of stem cell tube; E - Stem cell tube after centrifugation; F - Asp...
Figure_S3.jpg Jun 18, 2024 - Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects JPEG Image - 265.9 KB - MD5: a28557b38bcd078b822bc336e7305887 Mean PI, GI, PPD & CAL scores between different time intervals in control and test sites
Figure_S4.jpg Jun 18, 2024 - Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects JPEG Image - 234.1 KB - MD5: b4e85a49a03bbf27e241725e166c32e6 Mean Defect Depth & Defect Fill scores between different time intervals in control and test sites
Figure_S5.jpg Jun 18, 2024 - Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects JPEG Image - 215.1 KB - MD5: 3909f4d1fc10aeb5f677cd43d5bd9d76 EHI scores between control and test sites at 1 week
Figure_S6.jpg Jun 18, 2024 - Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects JPEG Image - 126.5 KB - MD5: 8184166698063dd750f57a1dc2b8929b Linear measurements on digitized images; 6A – Pre-operative measurements in control group; 6B – 3months post-operative measurements in control group; 6C – 6months post-operative measurements in control group; 6D - Pre-operative measurements in test group; 6E - 3months post-operat...
README.txt Jun 18, 2024 - Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects Plain Text - 3.7 KB - MD5: 72d4f4f23885dbb35caf8b91875269b1
Table_1.tab Jun 18, 2024 - Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects Tabular Data - 343 B - 5 Variables, 9 Observations - UNF:6:qJcR0zl7NPoMwT/8/XtPlw== Age and Gender distribution among study subjects
Table_2.tab Jun 18, 2024 - Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects Tabular Data - 1.6 KB - 16 Variables, 17 Observations - UNF:6:tKd7UePnuCkNGV2tgSt3Lg== Comparison of mean clinical parameters between Control & Test sites at baseline, 3 Months & 6 Months period using Wilcoxon Signed Ranked Test
Table_3.tab Jun 18, 2024 - Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects Tabular Data - 525 B - 9 Variables, 9 Observations - UNF:6:tVkMkuh236COgMWZVvRhIg== Comparison of mean Defect Depth between different time intervals in control and test sites using Friedman's test followed by Wilcoxon Signed Rank Post hoc Analysis

Figure_S1.jpg

Jun 18, 2024 - Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects

JPEG Image - 131.7 KB -

Consort flowchart for patient enrolment, allocation, follow-up, and analysis.

Figure_S2.jpg

Jun 18, 2024 - Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects

JPEG Image - 514.0 KB -

Merisis Supercell glue kits (PRFM+ stem cell) and Fabrication steps of Supercell glue. A - Withdrawal of 9 ml of venous blood; B - Merisis stem cell tube; C blood transferred to stem cell tube; D – Centrifugation of stem cell tube; E - Stem cell tube after centrifugation; F - Asp...

Figure_S3.jpg

Jun 18, 2024 - Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects

JPEG Image - 265.9 KB -

Mean PI, GI, PPD & CAL scores between different time intervals in control and test sites

Figure_S4.jpg

Jun 18, 2024 - Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects

JPEG Image - 234.1 KB -

Mean Defect Depth & Defect Fill scores between different time intervals in control and test sites

Figure_S5.jpg

Jun 18, 2024 - Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects

JPEG Image - 215.1 KB -

EHI scores between control and test sites at 1 week

Figure_S6.jpg

Jun 18, 2024 - Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects

JPEG Image - 126.5 KB -

Linear measurements on digitized images; 6A – Pre-operative measurements in control group; 6B – 3months post-operative measurements in control group; 6C – 6months post-operative measurements in control group; 6D - Pre-operative measurements in test group; 6E - 3months post-operat...

README.txt

Jun 18, 2024 - Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects

Plain Text - 3.7 KB -

Table_1.tab

Jun 18, 2024 - Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects

Tabular Data - 343 B - 5 Variables, 9 Observations -

Age and Gender distribution among study subjects

Table_2.tab

Jun 18, 2024 - Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects

Tabular Data - 1.6 KB - 16 Variables, 17 Observations -

Comparison of mean clinical parameters between Control & Test sites at baseline, 3 Months & 6 Months period using Wilcoxon Signed Ranked Test

Table_3.tab

Jun 18, 2024 - Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects

Tabular Data - 525 B - 9 Variables, 9 Observations -

Comparison of mean Defect Depth between different time intervals in control and test sites using Friedman's test followed by Wilcoxon Signed Rank Post hoc Analysis

Add Data

Share Dataverse

Link Dataverse

Reset Modifications